210 related articles for article (PubMed ID: 26777041)
21. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
[TBL] [Abstract][Full Text] [Related]
22. Study of primary IGF-1 deficiency in Egyptian children with idiopathic short stature.
Anwar GM; Kandeel WA; Mandour IA; Kamal AN
Horm Res Paediatr; 2013; 79(5):277-82. PubMed ID: 23635650
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature.
Hughes IP; Harris M; Choong CS; Ambler G; Cutfield W; Hofman P; Cowell CT; Werther G; Cotterill A; Davies PS;
Clin Endocrinol (Oxf); 2012 Jul; 77(1):62-71. PubMed ID: 21950731
[TBL] [Abstract][Full Text] [Related]
24. The basis for optimising growth with growth hormone usage in children with idiopathic short stature: analysis of data from KIGS (Pfizer International Growth Study Database).
Ranke MB; Lindberg A
Horm Res Paediatr; 2011; 76 Suppl 3():48-50. PubMed ID: 21912166
[TBL] [Abstract][Full Text] [Related]
25. Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.
Cohen P; Weng W; Rogol AD; Rosenfeld RG; Kappelgaard AM; Germak J
Clin Endocrinol (Oxf); 2014 Jul; 81(1):71-6. PubMed ID: 24428305
[TBL] [Abstract][Full Text] [Related]
26. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature.
Ying YQ; Hou L; Liang Y; Wu W; Luo XP
Growth Horm IGF Res; 2018; 42-43():80-85. PubMed ID: 30343148
[TBL] [Abstract][Full Text] [Related]
28. Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop.
Cohen P; Rogol AD; Deal CL; Saenger P; Reiter EO; Ross JL; Chernausek SD; Savage MO; Wit JM;
J Clin Endocrinol Metab; 2008 Nov; 93(11):4210-7. PubMed ID: 18782877
[TBL] [Abstract][Full Text] [Related]
29. Metabolic benefits of growth hormone therapy in idiopathic short stature.
Dahlgren J
Horm Res Paediatr; 2011; 76 Suppl 3():56-8. PubMed ID: 21912170
[TBL] [Abstract][Full Text] [Related]
30. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
31. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF; Miller BS; Dutailly P; Houchard A; Lawson E; Hale DE; Reiner B; Sperling MA;
Horm Res Paediatr; 2015; 83(4):268-79. PubMed ID: 25765099
[TBL] [Abstract][Full Text] [Related]
32. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.
Thalange NK; Price DA; Gill MS; Whatmore AJ; Addison GM; Clayton PE
Pediatr Res; 1996 May; 39(5):849-55. PubMed ID: 8726240
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone/IGF-I axis and growth hormone receptor mutations in idiopathic short stature.
El Kholy M; Mella P; Rashad M; Buzi F; Meazza C; Zahra S; Elsedfy HH
Horm Res Paediatr; 2011; 76(5):300-6. PubMed ID: 21846964
[TBL] [Abstract][Full Text] [Related]
36. Principles of growth hormone and insulin-like growth factor-I treatment in children with idiopathic short stature.
Bang P
Horm Res Paediatr; 2011; 76 Suppl 3():24-6. PubMed ID: 21912155
[TBL] [Abstract][Full Text] [Related]
37. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
[TBL] [Abstract][Full Text] [Related]
38. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
[TBL] [Abstract][Full Text] [Related]
39. Relationship between hemoglobin and insulin-like growth factor-1 in children and adolescents with idiopathic short stature.
Zhao Q; Zhang M; Ji B; Chu Y; Pan H; Yan W; Ban B
BMC Endocr Disord; 2020 Aug; 20(1):119. PubMed ID: 32746834
[TBL] [Abstract][Full Text] [Related]
40. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
